Company news

Orthocell Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Orthocell Receives A$2.1m R&D Tax Incentive Refund

June 2, 2022

Notification regarding unquoted securities - OCC

April 21, 2022

Regulatory Approval for Remplir Nerve Repair Device

March 20, 2022

Striate US Market Entry Update

February 27, 2022

Application for quotation of securities - OCC

December 30, 2021

Successful SmrtGraft Shoulder Study Published

December 15, 2021

OrthoATI Tendon Clinical Study Success

December 7, 2021

Ortho-ATI Shoulder Tendon Study Database Lock

November 14, 2021

Application for quotation of securities - OCC

November 9, 2021

Positive Data for CelGro Collagen Rope in ACL Reconstruction

September 14, 2021

OCC Secures Patents for Suture-Less Repair of Soft Tissue

September 7, 2021

Ortho-ATI Shoulder Tendon Study Update Revised

August 31, 2021

Ortho-ATI Shoulder Tendon Study Update

August 30, 2021

Appendix 4E and Annual Report to Shareholders

August 27, 2021

CelGro Facilitates Lymphatic Vessel Regeneration Updated

August 2, 2021

CelGro Facilitates Lymphatic Vessel Regeneration

August 1, 2021

Orthocell Appoints Exclusive Distributor in Australia

July 13, 2021

Positive CelGro Nerve Regeneration Results

June 20, 2021

OCC Secures Patents for Sutureless Repair of Soft Tissue

June 15, 2021

New Collagen Rope Patent for CelGro Platform Technology

May 25, 2021

CelGro Study Results Open Up New US Market Access Strategy

April 27, 2021

CelGro gains Australian reimbursement

March 2, 2021

Orthocell receives new US patent for CelGro

February 15, 2021

CelGro Recommended for Reimbursement

February 4, 2021

Orthocell Receives A$2.3m R&D Tax Incentive Refund

January 19, 2021

Orthocell Receives US Market Clearance

January 15, 2021

Orthocell Receives First US CelGro Product Approval

January 13, 2021

CelGro Receives Australian Market Approval

December 22, 2020

CelGro Completes Pivotal Step in TGA Approval Process

December 16, 2020

Positive Results in CelGro Nerve Repair Study

November 19, 2020

CelGro Bone Regeneration in Dental & Orthopedic Applications

September 16, 2020

CelGro Nerve Repair AUS Regulatory Application Submitted

July 29, 2020

Orthocells Ortho-ATI Shows 87.5% Success Rate

July 8, 2020

CelGro US 510(k) Submission Completed

May 11, 2020

Successful CelGro US Bone Repair Study

March 10, 2020

US Nerve Repair Study Design Meets FDA Requirements

December 15, 2019

SPP Offer Document and Terms And Conditions

December 5, 2019

Placement and Share Purchase Plan

December 3, 2019

CelGro Nerve Regeneration Results in Quadriplegic Patients

October 8, 2019

Successful CelGro Tendon Regeneration Trial

September 3, 2019

CelGro Study Validates High Quality Nerve Repair

July 25, 2019

CelGro Accelerates Dental Implant Treatments

June 18, 2019

Orthocell announces successful capital raising

May 30, 2019

First Patients Complete Nerve Regeneration Trial

May 7, 2019

Orthocell Submits AUS Regulatory Application for CelGro

April 30, 2019

Orthocells Ortho-ATI shows 82% success rate

February 12, 2019

CelGro Approved in Key UK Public Dental Hospital

December 10, 2018

Share Placement Successfully Raises $1.8m

December 10, 2018

Patient Treatment Completed in Dental Implant Study

November 28, 2018

OCC Receives New Patents for Celgro Platform Technology

November 1, 2018

← Newer news releases · Older news releases →

Decks

The 5 newest of 35 decks. Every deck is listed under its year.